Ann: Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data, page-120

Anything ' Non COVID-19 ' is simply superfluous to the main Pharmaceutical Game at the present moment , and hence a massive ' Flight to Quality ' being undertaken not just in this Industry but others right across the board as well.

I suppose you can take some comforts in the fact that having COH as at 31 December of $27.164 million together with trade and other receivables of another $7.80 million for a total of $34.964 million. On top of this you received in January a further R&D Tax Incentive refund of A$7,560,856 forthe 2018 / 2019 financial year which would then bring the total available Cash on Hand to some $42.5 million . And all this against current liabilities of only $2.035 million and estimated expenses represented largely by Research and Development expenses of $8.380 ( approx 57.2 % ). So it would not be unreasonable to expect a static or similar COH figure as at 31st March 2020.

So quite a strong position to be in while you wait this crisis out or re-direct some of your resources and / or testing capabilities into any possible COVID-19 solution processes and or discoveries. I particularly like the recent announcement where they spoke of the ineffectiveness in some cases of Nasal Bactroban ( mupirocin ) used in the pre-surgical environments. And this may become an even more important feature in our overall Health Systems.

There should also be some comfort taken by the Biotech Industry from the Governments Announcement announcement today of the creation of a Commission compiled from a vast range of Private Sector Industry Experts - none the least being David Thodey who as you ALL would know as the Chairman of the Board of CSIRO.

So IMO , after watching BOT very closely by the sidelines for sometime now , I have now entered with a position on the basis of my view of this recent drop being perhaps one of the more exceptional and unique buying opportunities.......

The COVID-19 Coordination Commission will include eminent Australians from the private and public sector, and be chaired by Nev Power, the former chief executive of Fortescue, with David Thodey to be deputy chairman.

Already on the board is former Labor MP Greg Combet, Jane Halton, the former head of the Finance Department, Paul Little the head of Toll, Catherine Tanna of Energy Australia, Phil Gaetjens the Secretary of the Department of Prime Minister and Cabinet, and Secretary of the Home Affairs Department Mike Pezzullo.

Mr Power said his role is going to be looking for opportunities to join businesses together to solve problems.

"Where there is a workforce that is no longer gainfully employed and where there is a workforce that's needed. Where there's equipment that can be re-deployed. Where we need to intervene to protect our critical supply chains and our utilities, and also, very importantly, looking to the future because we know that this virus will come and go," he said.